))
Synthetic Biology: Challenges in Scale Up- Subramani Ramachandrappa
Manage episode 359789986 series 3356187
Sisällön tarjoaa TechSprouts by Ankur Capital. TechSprouts by Ankur Capital tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
We are entering the third decade of synthetic biology. Many synbio products are either commercialized or on the verge of commercialization. However, scaling up the production while achieving price parities will require innovation in the processes and unit operations involved. Listen to Subramani Ramachandrappa, founder of Laurus Bio (formerly Richcore Lifesciences) and Fermbox talk about the challenges and potential solutions in the scale up of synthetic biology solutions.
Bio: https://www.linkedin.com/in/subramani-ramachandrappa-7179b82/
Website: https://fermbox.bio/
TechSprouts: https://www.ankurcapital.com/techsprouts
15 jaksoa
Jaa
